A Systematic Review and Meta-Analysis of the Association Between Polycystic Ovary Syndrome and Coronary Artery Calcification
- PMID: 35575750
- PMCID: PMC9360175
- DOI: 10.1089/jwh.2021.0608
A Systematic Review and Meta-Analysis of the Association Between Polycystic Ovary Syndrome and Coronary Artery Calcification
Abstract
Background: Polycystic ovary syndrome (PCOS) is a common endocrine pathology affecting women of reproductive age characterized by chronic anovulation, hyperandrogenism, and polycystic ovaries. Coronary artery calcification (CAC) is a marker of subclinical atherosclerosis and prognostic of cardiovascular disease (CVD) risk. Some studies have shown that women with PCOS have a greater risk of CAC; however, a few others report contrary findings. The objective of this study is to examine and quantify the association between PCOS and CAC. Materials and Methods: We searched EMBASE, Google Scholar, PubMed, and Web of Science from inception to November 2021 to identify studies that provided information on PCOS and CAC. We used a random-effects model to aggregate the odds ratios (ORs) for CAC (score >0) among women with PCOS compared with controls adjusted for sociodemographic characteristics and CVD risk factors. Results: From the 36 articles reviewed, 3 prospective cohort and 4 cross-sectional studies met the inclusion criteria with a total of 2341 participants. Six studies used CAC > 0 as an outcome and were included in the pooled analysis. Using the Hartung-Knapp-Sidik-Jonkman method, the pooled adjusted ORs for the associations between PCOS and the presence of CAC were 2.48 (95% confidence interval: 2.11-2.84) with no significant heterogeneity (I2 = 0.10%, p = 0.97) for the cohort studies and 1.88 (0.71-3.06) with no significant heterogeneity (I2 = 13.95%, p = 0.87) for the cross-sectional studies. Conclusion: In pooled analyses, women with PCOS had approximately twofold greater odds of having CAC compared with women without PCOS. However, additional prospective studies will be needed to further understand the relationship between PCOS and CAC.
Keywords: atherosclerosis; cardiovascular disease; coronary artery calcification; polycystic ovary syndrome; risk factors.
Conflict of interest statement
E.D.M. has served on advisory boards for AstraZeneca, Amarin, Bayer, Boehringer Ingelheim, Esperion, Novartis, Novo Nordisk, and Pfizer. The other authors have no conflicts of interest to disclose.
Figures



Similar articles
-
Prospective association of polycystic ovary syndrome with coronary artery calcification and carotid-intima-media thickness: the Coronary Artery Risk Development in Young Adults Women's study.Arterioscler Thromb Vasc Biol. 2014 Dec;34(12):2688-94. doi: 10.1161/ATVBAHA.114.304136. Epub 2014 Oct 30. Arterioscler Thromb Vasc Biol. 2014. PMID: 25359859
-
Is there an independent effect of polycystic ovary syndrome (PCOS) and menopause on the prevalence of subclinical atherosclerosis in middle aged women?Vasc Health Risk Manag. 2008;4(2):453-62. doi: 10.2147/vhrm.s1452. Vasc Health Risk Manag. 2008. PMID: 18561521 Free PMC article.
-
Complement protein C3 and coronary artery calcium in middle-aged women with polycystic ovary syndrome and controls.Gynecol Endocrinol. 2014 Jul;30(7):511-5. doi: 10.3109/09513590.2014.895985. Epub 2014 Mar 5. Gynecol Endocrinol. 2014. PMID: 24592986 Free PMC article.
-
Cardiovascular events among reproductive and menopausal age women with polycystic ovary syndrome: a systematic review and meta-analysis.Gynecol Endocrinol. 2020 Jan;36(1):12-23. doi: 10.1080/09513590.2019.1650337. Epub 2019 Aug 6. Gynecol Endocrinol. 2020. PMID: 31385729
-
Investigation of common risk factors between polycystic ovary syndrome and Alzheimer's disease: a narrative review.Reprod Health. 2021 Jul 26;18(1):156. doi: 10.1186/s12978-021-01203-x. Reprod Health. 2021. PMID: 34311759 Free PMC article. Review.
Cited by
-
Hyperandrogenism and Cardiometabolic Risk in Pre- and Postmenopausal Women-What Is the Evidence?J Clin Endocrinol Metab. 2024 Apr 19;109(5):1202-1213. doi: 10.1210/clinem/dgad590. J Clin Endocrinol Metab. 2024. PMID: 37886900 Free PMC article. Review.
-
The Current and Emerging Role of Statins in the Treatment of PCOS: The Evidence to Date.Medicina (Kaunas). 2024 Jan 30;60(2):244. doi: 10.3390/medicina60020244. Medicina (Kaunas). 2024. PMID: 38399531 Free PMC article. Review.
-
Sex-specific differences in cardiovascular risk factors and implications for cardiovascular disease prevention in women.Atherosclerosis. 2023 Nov;384:117269. doi: 10.1016/j.atherosclerosis.2023.117269. Epub 2023 Sep 4. Atherosclerosis. 2023. PMID: 37752027 Free PMC article. Review.
-
A Woman's Heart: Improving Uptake and Awareness of Cardiovascular Screening for Middle-Aged Populations.Int J Womens Health. 2023 Jul 24;15:1171-1183. doi: 10.2147/IJWH.S328441. eCollection 2023. Int J Womens Health. 2023. PMID: 37520181 Free PMC article. Review.
-
Assisted reproductive technology: what are the cardiovascular risks for women?Expert Rev Cardiovasc Ther. 2023 Jul-Dec;21(10):663-673. doi: 10.1080/14779072.2023.2266355. Epub 2023 Oct 26. Expert Rev Cardiovasc Ther. 2023. PMID: 37779500 Free PMC article. Review.
References
-
- Stein IF. Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 1935;29:181–191.
-
- ACOG Practice Bulletin No. 194: Polycystic ovary syndrome. Obstet Gynecol 2018;131:e157–e171. - PubMed
-
- Rasquin Leon LI. Polycystic Ovarian Disease. StatPearls, Treasure Island, Florida, USA. 2020.
-
- Bozdag G, Mumusoglu S, Zengin D, Karabulut E, Yildiz BO. The prevalence and phenotypic features of polycystic ovary syndrome: A systematic review and meta-analysis. Hum Reprod 2016;31:2841–2855. - PubMed
-
- Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R. Polycystic ovary syndrome: Etiology, pathogenesis and diagnosis. Nat Rev Endocrinol 2011;7:219–231. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous